SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-007977
Filing Date
2021-02-04
Accepted
2021-02-04 21:45:43
Documents
2
Period of Report
2021-02-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6226
2 POA DOCUMENT poa.txt EX-24.3_960337 3661
  Complete submission text file 0001209191-21-007977.txt   11299
Mailing Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O VOR BIOPHARMA INC. 100 CAMBRIDGEPARK DRIVE, SUITE 400 CAMBRIDGE MA 02140
Business Address
Jorgensen Nathan D. (Reporting) CIK: 0001842523 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39979 | Film No.: 21593203